Basel Medical BMGL
NASDAQ BMGL
$4.68 -0.26 (-5.26%)
At close: Sep 3, 2026 · 4:00 PM EDT

Basel Medical (BMGL) Operating Expenses (2023 - 2025)

Basel Medical (BMGL) posted Operating Expenses of -$471469.0 for Q4 2024.

Analysis

Basel Medical (BMGL) Operating Expenses (2023 - 2025) Analysis & Trends

Basel Medical has reported Operating Expenses for 1 years, with the latest figure at -$471469.0 in Q4 2024.

  • Quarterly Operating Expenses changed N/A year-over-year to -$471469.0 in Q4 2024, while the trailing twelve-month figure through Dec 2025 was -$471469.0 (changed N/A YoY) and the FY2025 annual result came in at $106478.4, up 4430.18% from the prior year.
  • Operating Expenses steadied at -$471469.0 in Q4 2024 per BMGL's latest filing.
  • Over five years, Operating Expenses peaked at -$471469.0 in Q4 2024 and troughed at -$471469.0 in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 HCA Healthcare 89.17 Bn 88.15 Bn 15.19 Bn 17.74 Bn
2 Tenet Healthcare 22.04 Bn 19.87 Bn 4.45 Bn 3.00 Mn
3 Encompass Health 12.07 Bn 11.94 Bn 1.34 Bn 1.31 Bn
4 Davita 11.84 Bn 11.16 Bn 1.16 Bn 2.98 Bn
5 Universal Health Services 10.14 Bn 10.00 Bn 3.29 Bn 4.12 Bn
6 Ensign 9.95 Bn 9.63 Bn 306.24 Mn 1.32 Bn
7 Chemed 6.85 Bn 6.81 Bn 221.47 Mn 584.05 Mn
8 Pacs 6.77 Bn 6.61 Bn 338.46 Mn 1.32 Bn
9 Concentra Group Holdings Parent 4.30 Bn 4.15 Bn 192.10 Mn 490.51 Mn
10 Basel Medical 7.33 Mn 6.54 Mn - -2.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -2.06 Mn
Jun 30, 2025 107,659.00
Dec 31, 2024 -471,469.00
Dec 31, 2023 -268,299.00